 |
|
|
 |
|
XEMEX Hemostatic Device T Type
(Japanese Product Name: Tometa-kun) |
|
This innovative hemostatic device overcomes the disadvantages of an involved
hemostatic management procedure, making its standardization possible.
Suitable for post-CAG and post-PCI.
Device consists of a hemostatic bag, a pressure device and a support device,
depending on the approach site of application.
(The support device is only used for hemostasis of the femoral artery.)
The sterilized hemostatic bag can be used immediately.
. |
|
|
|
 |
|
Properties and Characteristics |
|
|
|
|
|
 |
The original pressure device can be connected to a hemostatic bag only
to prevent improper connection. |
|
Safe hemostasis can be achieved with visual confirmation of the treatment
site. |
|
Hemostasis can be achieved by simply adjusting the volume of air in the
bag with the pressure device. |
|
The hemostasis process is greatly simplified. |
|
The risk of complications can be minimized by application of appropriate
pinpoint pressurization. |
|
Patient's discomfort is considerably reduced. |
|
STB300 and STB500 are also available for a secondary hemostasis. |
|
|
|
|
 |
|
|
|
|
|
|
|
|
Set pressure |
Time |
| Initial pressurization |
Systolic blood pressure +10-20 mmHg (pressure applied until peripheral
artery pulse is not transmitted) |
3-15 minutes |
| Second pressure reduction stage |
Intermediate pressure between the systolic blood pressure and the diastolic
blood pressure (pressure applied until the pulse at a peripheral artery
is transmitted) |
15-60 minutes |
| Third pressure reduction stage |
Diastolic blood pressure -10 mmHg |
15-60 minutes |
| Fourth pressure reduction stage |
10-20 mmHg (Start of secondary hemostasis) |
To be relieved as appropriate |
|
|
|
|
|
The above description represents a general protocol.
Specific protocols must be established to ensure appropriate care for each
case, since the time required for bleeding to stop depends on such factors
as the quantity of heparin consumed, the time taken for the procedure,
diameter of sheath introducer, type of drug administered, and the patient's
physiological condition.
To stop bleeding, apply appropriate pressure to stop bleeding at any hemostatic
stage. |
|
|
|
|
|
|
|
